ClinicalTrials.Veeva

Menu

Potential Role of CMV in Restenosis Following Angioplasty, in Atherosclerosis, and in Endothelial Dysfunction

National Institutes of Health (NIH) logo

National Institutes of Health (NIH)

Status

Completed

Conditions

Arterial Occlusive Diseases
Cytomegalovirus Infections
Coronary Disease
Atherosclerosis

Study type

Observational

Funder types

NIH

Identifiers

NCT00001531
96-H-0099
960099

Details and patient eligibility

About

The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.

Full description

The purpose of this study is to investigate whether the susceptibility of subjects to atherosclerosis is influenced by prior CMV exposure, whether the susceptability to endothelial dysfunction in patients with and in patients without atherosclerosis is influenced by prior CMV exposure.

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Patients who are being evaluated to determine if they have CAD or those who have already been studied and the presence or absence of CAD has been ascertained.

No patients who have not been evaluated for CAD.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems